An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients
Top Cited Papers
Open Access
- 10 August 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 143 (11), 2758-2766
- https://doi.org/10.1002/ijc.31785
Abstract
Regarding the continuous changes in the diagnostic process and treatment of colorectal cancer (CRC), it is important to evaluate long‐term trends which are relevant in giving direction for further research and innovations in cancer patient care. The aim of this study was to analyze developments in incidence, treatment and survival for patients diagnosed with CRC in the Netherlands. For this population‐based retrospective cohort study, all patients diagnosed with CRC between 1989 and 2014 in the Netherlands were identified using data of the nationwide population‐based Netherlands Cancer Registry (n = 267,765), with follow‐up until January 1, 2016. Analyses were performed for trends in incidence, mortality, stage distribution, treatment and relative survival measured from the time of diagnosis. The incidence of both colon and rectal cancer has risen. The use of postoperative chemotherapy for Stage III colon cancer increased (14–60%), as well as the use of preoperative (chemo)radiotherapy for rectal cancer (2–66%). The administration of systemic therapy and metastasectomy increased for Stage IV disease patients. The 5‐year relative survival increased significantly from 53 to 62% for colon cancer and from 51 to 65% for rectal cancer. Ongoing advancements in treatment, and also improvement in other factors in the care of CRC patients—such as diagnostics, dedicated surgery and pre‐ and postoperative care—lead to a continuous improvement in the relative survival of CRC patients. The increasing incidence of CRC favors the implementation of the screening program, of which the effects should be monitored closely.Keywords
Funding Information
- Radboud Universitair Medisch Centrum
- Department of Surgery
This publication has 38 references indexed in Scilit:
- Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The NetherlandsActa Oncologica, 2013
- Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal CancerAnnals of Surgical Oncology, 2012
- Use of Primary Radiotherapy for Rectal Cancer in the Netherlands between 1997 and 2008: A Population-based StudyClinical Oncology, 2012
- On Estimation in Relative SurvivalBiometrics, 2011
- Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population‐based seriesColorectal Disease, 2010
- Trends in colorectal cancer in the south of the Netherlands 1975–2007: Rectal cancer survival levels with colon cancer survivalActa Oncologica, 2010
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC TrialJournal of Clinical Oncology, 2009
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerThe New England Journal of Medicine, 2001
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaThe New England Journal of Medicine, 1990